Ph.D. in Neurobiology (USTC) and B.E. in Bioengineering (CUMT), offering a unique interdisciplinary background spanning life sciences and engineering. Focuses on PE investment in innovative drugs and high-value medical devices, with multiple closed deals in the sector.